On Oct. 9, 2023 a publication (Clinical Cancer Research) announced a new ovarian cancer screening test. The new test is called OvaPrint™. A total of 372 samples were examined for this paper. OvaPrint™ achieved a positive predictive value of 95% and a negative predictive value of 88%.